Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Declines By 69.5%

INVO Bioscience, Inc. (NASDAQ:INVO) was the target of a large decrease in short interest in August. As of August 15th, there was short interest totalling 151,700 shares, a decrease of 69.5% from the July 31st total of 496,600 shares. Based on an average daily trading volume, of 196,100 shares, the short-interest ratio is presently 0.8 days. Approximately 3.9% of the shares of the stock are short sold.

INVO Bioscience Price Performance

Shares of INVO Bioscience stock traded down $0.02 during midday trading on Tuesday, hitting $0.80. 159,426 shares of the company were exchanged, compared to its average volume of 1,567,725. The firm has a 50 day simple moving average of $0.84 and a 200-day simple moving average of $0.94. INVO Bioscience has a 52 week low of $0.50 and a 52 week high of $3.50.

About INVO Bioscience

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.